Australia's largest stock trading and investment forum Australia's #1 stock forum

AC8 auscann group holdings ltd

0.00%

4.0¢

Ann: Initial Director's Interest Notice - A. Chapman, page-6

First 6 Last

Share
Profile

Follow
Cylon

122 Posts.

3

12/12/23

17:03

Post #: 71409826
Share

Originally posted by AusCannOfficial: ↑

I can't speak to the past board members salaries from inception but at the moment the salary pool for the 3 board members totals $170k all up so certainly not $500k each...over the last little while we have cut all costs and attempted to put the company in a position that it is pretty much cash flow neutral.

Neuvis - the original AC8 Management team spent a lot of time and money trying to get a product to market as a delivery system for medical cannabis. Unfortunately they were doing this before there was an actual market and without actual knowledge of what the market looked like - AC8 isn't on their own in this regard as the MC market as we know it has changed and morphed almost on a monthly basis since it was first introduced in 2018. To give you an idea other companies in the sector built facilities to cater for 75 tn of product per annum only to realise 5 years later that the overall market in Oz for Medical product is maximum - 25 tn per annum. What I don't think anyone in the industry foresaw was that circa 75% of Medical Cannabis users are actually Recreational users just accessing better quality product...there is a reason why 75% of sales of Medical Cannabis in Oz (and around the world for that matter) is flower when arguably the best way to access pure Medical product, is via an extract...Unfortunately with every start up business and start up industry, there are twists and turns and money is sometimes not spent in the right areas. At the time, the board and management did what they thought was best with the information they had at the time. Only with hindsight has it proven to be incorrect. We are currently looking at options to sell Neuvis but do not have a suitable solution at this time.

CannPal - a good little company but scale was an issue and it needed a lot more money spent on it that the AC8 board decided wasn't in the best interests of shareholders. Again the regulatory pathway for CannPal changed and the AC8 board made the strategic decision that spending the companies money in an area that the market wasn't rewarding, was a pointless exercise so we have maintained a carried interest of 48% of the equity in CannPal while Layton pursues commercial funding partners for its development. We are confident Layton will achieve his goal with it and AC8 will have an uplift in time on the balance sheet, as a result.

As soon as we have more information on the future direction of AC8 we will communicate this - but I can tell you all - it won't be long from here.

Expand

on behalf of all share holders and i, thank you for your (quick) response, it feels like a cool breeze on the face on a hot day, yer.

soo,, am i anywhere near to an understanding that, that the neuvis product resulted from the SEED research, which i believe, ended in failure by previous company, then taken up by ac8? did ac8 bm's realize this product to be a dog (no disrespect to real dogs) and soo bought into canpal?

just a question that you may find stupid but... do all on ac8 payroll work full time for this company and, again i show my ignorance, is there a place to validate.
cheers
just luuuve your response time;.

AC8 Price at posting: 4.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

AII

Inside the Depths of Panasqueira: A Legacy Carved in Rock

Trump chides Powell as Goldman call for calm. The RBA must be nervous

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

DMP

Is Domino's a steal after -25% plunge?

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

First 6 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

SPONSORED BY